相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pyronaridine: An update of its pharmacological activities and mechanisms of action
Christian Bailly
BIOPOLYMERS (2021)
Defining the Antimalarial Activity of Cipargamin in Healthy Volunteers Experimentally Infected with Blood-Stage Plasmodium falciparum
James S. McCarthy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Repurposing of antitumor drug candidate Quisinostat lead to novel spirocyclic antimalarial agents
Ruoxi Li et al.
CHINESE CHEMICAL LETTERS (2021)
Chemoprotective Antimalarial Activity of P218 against Plasmodium falciparum: A Randomized, Placebo-Controlled Volunteer Infection Study
Mohamed Farouk Chughlay et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2021)
Efficient Treatment of Experimental Cerebral Malaria by an Artemisone-SMEDDS System: Impact of Application Route and Dosing Frequency
Johanna Zech et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Transgenic pyrimethamine-resistant plasmodium falciparum reveals transmission-blocking potency of P218, a novel antifolate candidate drug
Navaporn Posayapisit et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2021)
A Single-Dose Combination Study with the Experimental Antimalarials Artefenomel and DSM265 To Determine Safety and Antimalarial Activity against Blood-Stage Plasmodium falciparum in Healthy Volunteers
James S. McCarthy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Preclinical Antimalarial Combination Studies: The Case of M5717, a P. falciparum Elongation Factor 2 Inhibitor and Pyronaridine, a Hemozoin Formation Inhibitor
Matthias Rottmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
In Vivo Efficacy and Pharmacokinetics of the 2-Aminomethylphenol Antimalarial JPC-3210 in the Aotus Monkey-Human Malaria Model
Fiona J. McCallum et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
First-in-human clinical trial to assess the safety, tolerability and pharmacokinetics of P218, a novel candidate for malaria chemoprotection
M. Farouk Chughlay et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Multi-omic Characterization of the Mode of Action of a Potent New Antimalarial Compound, JPC-3210, Against Plasmodium falciparum
Geoffrey W. Birrell et al.
MOLECULAR & CELLULAR PROTEOMICS (2020)
Improving solubility and oral bioavailability of a novel antimalarial prodrug: comparing spray-dried dispersions with self-emulsifying drug delivery systems
Suresh Potharaju et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2020)
A Phase 1, Placebo-controlled, Randomized, Single Ascending Dose Study and a Volunteer Infection Study to Characterize the Safety, Pharmacokinetics, and Antimalarial Activity of the Plasmodium Phosphatidylinositol 4-Kinase Inhibitor MMV390048
James S. McCarthy et al.
CLINICAL INFECTIOUS DISEASES (2020)
Lead Optimization of Second-Generation Acridones as Broad-Spectrum Antimalarials
Papireddy Kancharla et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Pan-active imidazolopiperazine antimalarials target the Plasmodium falciparum intracellular secretory pathway
Gregory M. LaMonte et al.
NATURE COMMUNICATIONS (2020)
Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial
Aditya H. Gaur et al.
LANCET INFECTIOUS DISEASES (2020)
Treatment of Experimental Cerebral Malaria by Slow Release of Artemisone From Injectable Pasty Formulation
Jacob Golenser et al.
FRONTIERS IN PHARMACOLOGY (2020)
A novel multistage antiplasmodial inhibitor targeting Plasmodium falciparum histone deacetylase 1
Zhenghui Huang et al.
CELL DISCOVERY (2020)
Torin 2 Derivative, NCATS-SM3710, Has Potent Multistage Antimalarial Activity through Inhibition of P. falciparum Phosphatidylinositol 4-Kinase (Pf PI4KIIIß)
Karthik Krishnan et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
Discovery and Structural Optimization of Acridones as Broad-Spectrum Antimalarials
Rozalia A. Dodean et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
The past, present and future of anti-malarial medicines
Edwin G. Tse et al.
MALARIA JOURNAL (2019)
Characterization of Lipid Binding Properties of Plasmodium falciparum Acyl-Coenzyme A Binding Proteins and Their Competitive Inhibition by Mefloquine
Abhishek Kumar et al.
ACS CHEMICAL BIOLOGY (2019)
8-Aminoquinoline Therapy for Latent Malaria
J. Kevin Baird
CLINICAL MICROBIOLOGY REVIEWS (2019)
Tafenoquine: the new kid on the block
Victor Chen et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2019)
Ozonide Antimalarial Activity in the Context of Artemisinin-Resistant Malaria
Carlo Giannangelo et al.
TRENDS IN PARASITOLOGY (2019)
In vitro activity of ferroquine against artemisinin-based combination therapy (ACT)-resistant Plasmodium falciparum isolates from Cambodia
Melissa Mairet-Khedim et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
ELQ-331 as a prototype for extremely durable chemoprotection against malaria
Martin J. Smilkstein et al.
MALARIA JOURNAL (2019)
Antimalarial pantothenamide metabolites target acetyl-coenzyme A biosynthesis in Plasmodium falciparum
Joost Schalkwijk et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Plasmodium falciparum resistance to piperaquine driven by PfCRT
Satish K. Dhingra et al.
LANCET INFECTIOUS DISEASES (2019)
Safety and efficacy of artesunate-amodiaquine combined with either methylene blue or primaquine in children with falciparum malaria in Burkina Faso: A randomized controlled trial
Margarida Mendes Jorge et al.
PLOS ONE (2019)
NPC1161B, an 8-Aminoquinoline Analog, Is Metabolized in the Mosquito and Inhibits Plasmodium falciparum Oocyst Maturation
Timothy Hamerly et al.
FRONTIERS IN PHARMACOLOGY (2019)
Ozonide Antimalarials Alkylate Heme in the Malaria Parasite Plasmodium falciparum
Carlo Giannangelo et al.
ACS INFECTIOUS DISEASES (2019)
A brief history of artemisinin: Modes of action and mechanisms of resistance
Lu Feng et al.
CHINESE JOURNAL OF NATURAL MEDICINES (2019)
A Randomized Trial Evaluating the Prophylactic Activity of DSM265 Against Preerythrocytic Plasmodium falciparum Infection During Controlled Human Malarial Infection by Mosquito Bites and Direct Venous Inoculation
Sean C. Murphy et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Characterization of the Preclinical Pharmacology of the New 2-Aminomethylphenol, JPC-3210, for Malaria Treatment and Prevention
Geoffrey W. Birrell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Efficacy and safety of methylene blue in the treatment of malaria: a systematic review
G. Lu et al.
BMC MEDICINE (2018)
The antimalarial pipeline
Rob Hooft van Huijsduijnen et al.
CURRENT OPINION IN PHARMACOLOGY (2018)
Drugs in Development for Malaria
Elizabeth A. Ashley et al.
DRUGS (2018)
Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study
Alejandro Llanos-Cuentas et al.
LANCET INFECTIOUS DISEASES (2018)
A phase 1 evaluation of the pharmacokinetic/pharmacodynamic interaction of the anti-malarial agents KAF156 and piperaquine
F. Joel Leong et al.
MALARIA JOURNAL (2018)
Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum
Maelle Duffey et al.
MALARIA JOURNAL (2018)
Drug resistance in Plasmodium
Kasturi Haldar et al.
NATURE REVIEWS MICROBIOLOGY (2018)
Recent updates in the discovery and development of novel antimalarial drug candidates
John Okombo et al.
MEDCHEMCOMM (2018)
Artemisinin Derivatives and Synthetic Trioxane Trigger Apoptotic Cell Death in Asexual Stages of Plasmodium
Sarika Gunjan et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2018)
Estimation of the In Vivo MIC of Cipargamin in Uncomplicated Plasmodium falciparum Malaria
Tran Tinh Hien et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Structure-Activity Relationship of the Antimalarial Ozonide Artefenomel (OZ439)
Yuxiang Dong et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
AQ-13, an investigational antimalarial, versus artemether plus lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria: a randomised, phase 2, non-inferiority clinical trial
Ousmane A. Koita et al.
LANCET INFECTIOUS DISEASES (2017)
Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study
James S. McCarthy et al.
LANCET INFECTIOUS DISEASES (2017)
A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study
Benoit Witkowski et al.
LANCET INFECTIOUS DISEASES (2017)
DSM265 for Plasmodium falciparum chemoprophylaxis: a randomised, double blinded, phase 1 trial with controlled human malaria infection
Mihly Sulyok et al.
LANCET INFECTIOUS DISEASES (2017)
Safety and tolerability of adjunctive rosiglitazone treatment for children with uncomplicated malaria
Rosauro Varo et al.
MALARIA JOURNAL (2017)
New developments in anti-malarial target candidate and product profiles
Jeremy N. Burrows et al.
MALARIA JOURNAL (2017)
Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic
Benjamin Blasco et al.
NATURE MEDICINE (2017)
Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase
Tanya Paquet et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance
Paul M. O'Neill et al.
NATURE COMMUNICATIONS (2017)
SC83288 is a clinical development candidate for the treatment of severe malaria
Stefano Pegoraro et al.
NATURE COMMUNICATIONS (2017)
Alkoxycarbonate Ester Prodrugs of Preclinical Drug Candidate ELQ-300 for Prophylaxis and Treatment of Malaria
Lisa Frueh et al.
ACS INFECTIOUS DISEASES (2017)
Mefloquine targets the Plasmodium falciparum 80S ribosome to inhibit protein synthesis
Wilson Wong et al.
NATURE MICROBIOLOGY (2017)
Effects of sevuparin on rosette formation and cytoadherence of Plasmodium falciparum infected erythrocytes
Somporn Saiwaew et al.
PLOS ONE (2017)
Inhibition of merozoite invasion and transient de-sequestration by sevuparin in humans with Plasmodium falciparum malaria
Anna M. Leitgeb et al.
PLOS ONE (2017)
A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria
Fiona Macintyre et al.
BMC MEDICINE (2017)
Atovaquone and ELQ-300 Combination Therapy as a Novel Dual-Site Cytochrome bc1 Inhibition Strategy for Malaria
Allison M. Stickles et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Lead Selection of a New Aminomethylphenol, JPC-3210, for Malaria Treatment and Prevention
Marina Chavchich et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Mefloquine induces ROS mediated programmed cell death in malaria parasite: Plasmodium
Sarika Gunjan et al.
APOPTOSIS (2016)
Pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of Actelion-451840 in an induced blood stage malaria study in healthy subjects
Andreas Krause et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Discovery and Characterization of ACT-451840: an Antimalarial Drug with a Novel Mechanism of Action
Christoph Boss et al.
CHEMMEDCHEM (2016)
Naphthoquine: An Emerging Candidate for Artemisinin Combination Therapy
Brioni R. Moore et al.
DRUGS (2016)
Efficacy of OZ439 (artefenomel) against early Plasmodium falciparum blood-stage malaria infection in healthy volunteers
James S. McCarthy et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Discovery of a Quinoline-4-carboxamide Derivative with a Novel Mechanism of Action, Multistage Antimalarial Activity, and Potent in Vivo Efficacy
Beatriz Baragana et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Hit-to-Lead Studies for the Antimalarial Tetrahydroisoquinolone Carboxanilides
David M. Floyd et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial
Aung Pyae Phyo et al.
LANCET INFECTIOUS DISEASES (2016)
Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial
Pamela L. St Jean et al.
MALARIA JOURNAL (2016)
Cytochrome P450 2D-mediated metabolism is not necessary for tafenoquine and primaquine to eradicate the erythrocytic stages of Plasmodium berghei
Erin E. Milner et al.
MALARIA JOURNAL (2016)
Macrolides and associated antibiotics based on similar mechanism of action like lincosamides in malaria
Tiphaine Gaillard et al.
MALARIA JOURNAL (2016)
A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study
James S. McCarthy et al.
MALARIA JOURNAL (2016)
CRISPR-Cas9-modified pfmdr1 protects Plasmodium falciparum asexual blood stages and gametocytes against a class of piperazine-containing compounds but potentiates artemisinin-based combination therapy partner drugs
Caroline L. Ng et al.
MOLECULAR MICROBIOLOGY (2016)
Diversity-oriented synthesis yields novel multistage antimalarial inhibitors
Nobutaka Kato et al.
NATURE (2016)
Antimalarial Activity of KAF156 in Falciparum and Vivax Malaria
Nicholas J. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Primaquine pharmacology in the context of CYP 2D6 pharmacogenomics: Current state of the art
Sean R. Marcsisin et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Inhibition of an Erythrocyte Tyrosine Kinase with Imatinib Prevents Plasmodium falciparum Egress and Terminates Parasitemia
Kristina R. Kesely et al.
PLOS ONE (2016)
Artemisinin Action and Resistance in Plasmodium falciparum
Leann Tilley et al.
TRENDS IN PARASITOLOGY (2016)
Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling
Amelie Le Bihan et al.
PLOS MEDICINE (2016)
A Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitor with Improved Drug-like Properties for Treatment and Prevention of Malaria
Margaret A. Phillips et al.
ACS INFECTIOUS DISEASES (2016)
UDP-galactose and acetyl-CoA transporters as Plasmodium multidrug resistance genes
Michelle Yi-Xiu Lim et al.
NATURE MICROBIOLOGY (2016)
KAE609 (Cipargamin), a New Spiroindolone Agent for the Treatment of Malaria: Evaluation of the Absorption, Distribution, Metabolism, and Excretion of a Single Oral 300-mg Dose of [14C]KAE609 in Healthy Male Subjects
Su-Er W. Huskey et al.
DRUG METABOLISM AND DISPOSITION (2016)
A Pantetheinase-Resistant Pantothenamide with Potent, On-Target, and Selective Antiplasmodial Activity
Cristiano J. Macuamule et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Open-Label, Single-Dose, Parallel-Group Study in Healthy Volunteers To Determine the Drug-Drug Interaction Potential between KAE609 (Cipargamin) and Piperaquine
Daniel S. Stein et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
ELQ-300 Prodrugs for Enhanced Delivery and Single-Dose Cure of Malaria
Galen P. Miley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Tyrosine kinase inhibitors: New class of antimalarials on the horizon?
Vrushali Pathak et al.
BLOOD CELLS MOLECULES AND DISEASES (2015)
Fosmidomycin as an antimalarial drug: a meta-analysis of clinical trials
Jose Francisco Fernandes et al.
FUTURE MICROBIOLOGY (2015)
In celebration of the Jesuit's powder: a history of malaria treatment
Natalie Harrison
LANCET INFECTIOUS DISEASES (2015)
Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study
Jana Held et al.
LANCET INFECTIOUS DISEASES (2015)
A systematic review of the efficacy of a single dose artemisinin-naphthoquine in treating uncomplicated malaria
Cho Naing et al.
MALARIA JOURNAL (2015)
A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria
Alassane Mbengue et al.
NATURE (2015)
A novel multiple-stage antimalarial agent that inhibits protein synthesis
Beatriz Baragana et al.
NATURE (2015)
A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria
Margaret A. Phillips et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate
Shahul P. Hameed et al.
NATURE COMMUNICATIONS (2015)
Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum
Jigang Wang et al.
NATURE COMMUNICATIONS (2015)
First-in-Humans Study of the Safety, Tolerability, and Pharmacokinetics of ACT-451840, a New Chemical Entity with Antimalarial Activity
Shirin Bruderer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
JPC-2997, a New Aminomethylphenol with High In Vitro and In Vivo Antimalarial Activities against Blood Stages of Plasmodium
Geoffrey W. Birrell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Antimalarial Spiroindolone KAE609 (Cipargamin) To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers
F. Joel Leong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Imidazolopiperazine KAF156 To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers
F. Joel Leong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
KAF156 Is an Antimalarial Clinical Candidate with Potential for Use in Prophylaxis, Treatment, and Prevention of Disease Transmission
Kelli L. Kuhen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Discovery, Synthesis, and Optimization of Antimalarial 4(1H)-Quinolone-3-Diarylethers
Aaron Nilsen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds
Sean R. Marcsisin et al.
MALARIA JOURNAL (2014)
Malaria and Quinine Resistance: A Medical and Scientific Issue between Brazil and Germany (1907-19)
Andre Felipe Candido da Silva et al.
MEDICAL HISTORY (2014)
Spiroindolone KAE609 for Falciparum and Vivax Malaria
Nicholas J. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
(+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium
Maria Belen Jimenez-Diaz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
PPARγ Agonists Improve Survival and Neurocognitive Outcomes in Experimental Cerebral Malaria and Induce Neuroprotective Pathways in Human Malaria
Lena Serghides et al.
PLOS PATHOGENS (2014)
Fixed dose combination of arterolane and piperaquine: A newer prospect in antimalarial therapy
C. Y. Patil et al.
ANNALS OF MEDICAL AND HEALTH SCIENCES RESEARCH (2014)
Insights into the Role of Heme in the Mechanism of Action of Antimalarials
Jill M. Combrinck et al.
ACS CHEMICAL BIOLOGY (2013)
First-in-man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarials
Joerg J. Moehrle et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Na+ Regulation in the Malaria Parasite Plasmodium falciparum Involves the Cation ATPase PfATP4 and Is a Target of the Spiroindolone Antimalarials
Natalie J. Spillman et al.
CELL HOST & MICROBE (2013)
Designing the next generation of medicines for malaria control and eradication
Jeremy N. Burrows et al.
MALARIA JOURNAL (2013)
The metabolism of primaquine to its active metabolite is dependent on CYP 2D6
Brandon S. Pybus et al.
MALARIA JOURNAL (2013)
Targeting Plasmodium PI(4)K to eliminate malaria
Case W. McNamara et al.
NATURE (2013)
Pantothenamides Are Potent, On-Target Inhibitors of Plasmodium falciparum Growth When Serum Pantetheinase Is Inactivated
Christina Spry et al.
PLOS ONE (2013)
Torins are potent antimalarials that block replenishment of Plasmodium liver stage parasitophorous vacuole membrane proteins
Kirsten K. Hanson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Quinolone-3-Diarylethers: A New Class of Antimalarial Drug
Aaron Nilsen et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Pharmacokinetics of Ferroquine, a Novel 4-Aminoquinoline, in Asymptomatic Carriers of Plasmodium falciparum Infections
Christian Supan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
MK-4815, a Potential New Oral Agent for Treatment of Malaria
Mary Ann Powles et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
The Spiroindolone Drug Candidate NITD609 Potently Inhibits Gametocytogenesis and Blocks Plasmodium falciparum Transmission to Anopheles Mosquito Vector
J. C. van Pelt-Koops et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
3,5-Diaryl-2-aminopyridines as a Novel Class of Orally Active Antimalarials Demonstrating Single Dose Cure in Mice and Clinical Candidate Potential
Yassir Younis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Imidazolopiperazines: Lead Optimization of the Second-Generation Antimalarial Agents
Advait Nagle et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
CYP450 phenotyping and accurate mass identification of metabolites of the 8-aminoquinoline, anti-malarial drug primaquine
Brandon S. Pybus et al.
MALARIA JOURNAL (2012)
Review of pyronaridine anti-malarial properties and product characteristics
Simon L. Croft et al.
MALARIA JOURNAL (2012)
Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target
Yongyuth Yuthavong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The Activities of Current Antimalarial Drugs on the Life Cycle Stages of Plasmodium: A Comparative Study with Human and Rodent Parasites
Michael Delves et al.
PLOS MEDICINE (2012)
Imidazolopiperazines: Hit to Lead Optimization of New Antimalarial Agents
Tao Wu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies Potent Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors with Clinical Candidate Potential
Jose M. Coteron et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria
Jane Achan et al.
MALARIA JOURNAL (2011)
Phase I randomized dose-ascending placebo-controlled trials of ferroquine - a candidate anti-malarial drug - in adults with asymptomatic Plasmodium falciparum infection
Ghyslain Mombo-Ngoma et al.
MALARIA JOURNAL (2011)
Lest we forget you - methylene blue ...
R. Heiner Schirmer et al.
NEUROBIOLOGY OF AGING (2011)
Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria
Susan A. Charman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Azithromycin for treating uncomplicated malaria
Anna M. van Eijk et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2011)
Identification of a 1,2,4,5-Tetraoxane Antimalarial Drug-Development Candidate (RKA 182) with Superior Properties to the Semisynthetic Artemisinins
Paul M. O'Neill et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Arterolane, a New Synthetic Trioxolane for Treatment of Uncomplicated Plasmodium falciparum Malaria: A Phase II, Multicenter, Randomized, Dose-Finding Clinical Trial
Neena Valecha et al.
CLINICAL INFECTIOUS DISEASES (2010)
Toxicity of the antimalarial artemisinin and its dervatives
Thomas Efferth et al.
CRITICAL REVIEWS IN TOXICOLOGY (2010)
Transporters as mediators of drug resistance in Plasmodium falciparum
Cecilia P. Sanchez et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2010)
The Structure-Activity Relationship of the Antimalarial Ozonide Arterolane (OZ277)
Yuxiang Dong et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Spirotetrahydro β-Carbolines (Spiroindolones): A New Class of Potent and Orally Efficacious Compounds for the Treatment of Malaria
Bryan K. S. Yeung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Artemisone effective against murine cerebral malaria
Judith H. Waknine-Grinberg et al.
MALARIA JOURNAL (2010)
Thousands of chemical starting points for antimalarial lead identification
Francisco-Javier Gamo et al.
NATURE (2010)
Chemical genetics of Plasmodium falciparum
W. Armand Guiguemde et al.
NATURE (2010)
Spiroindolones, a Potent Compound Class for the Treatment of Malaria
Matthias Rottmann et al.
SCIENCE (2010)
Artemisinin-Naphthoquine Combination (ARCO®): An Overview of the Progress
Francis W. Hombhanje et al.
PHARMACEUTICALS (2010)
Use of Peroxisome Proliferator-Activated Receptor γ Agonists as Adjunctive Treatment for Plasmodium falciparum Malaria: A Randomized, Double-Blind, Placebo-Controlled Trial
Andrea K. Boggild et al.
CLINICAL INFECTIOUS DISEASES (2009)
Discovery, mechanisms of action and combination therapy of artemisinin
Liwang Cui et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2009)
Rosiglitazone Modulates the Innate Immune Response to Plasmodium falciparum Infection and Improves Outcome in Experimental Cerebral Malaria
Lena Serghides et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Discovery of dual function acridones as a new antimalarial chemotype
Jane X. Kelly et al.
NATURE (2009)
First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone
Johannes Nagelschmitz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Antiparasitic activities and toxicities of individual enantiomers of the 8-aminoquinoline 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-4-methyl-5-[3,4-dichlorophenoxy]quinoline succinate
N. P. Dhammika Nanayakkara et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors with potent and selective activity against the malaria parasite Plasmodium falciparum
Margaret A. Phillips et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Investigation of the redox behavior of ferroquine, a new antimalarial
Natascha Chavain et al.
MOLECULAR PHARMACEUTICS (2008)
Evidence of Artemisinin-Resistant Malaria in Western Cambodia
Harald Noedl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen
David Plouffe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Peroxide bond-dependent antiplasmodial specificity of arternisinin and OZ277 (RBx11160)
Marcel Kaiser et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Antimalarial efficacy and drug interactions of the novel semi-synthetic endoperoxide artemisone in vitro and in vivo
L. Vivas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
The effects of anti-bacterials on the malaria parasite Plasmodium falciparum
Christopher Dean Goodman et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2007)
Mechanism of antimalarial action of the synthetic trioxoane RBX11160 (OZ277)
Anne-Catrin Uhlemann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Evaluation and lead optimization of anti-malarial acridones
Rolf W. Winter et al.
EXPERIMENTAL PARASITOLOGY (2006)
Tetracyclines specifically target the picoplast of the malaria parasite Plasmodium falciparum
Erica L. Dahl et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin
Amar Bir Singh Sidhu et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
In vitro metabolism of ferroquine (SSR97193) in animal and human hepatic models and antimalarial activity of major metabolites on Plasmodium falciparum
W Daher et al.
DRUG METABOLISM AND DISPOSITION (2006)
Assessment of Plasmodium falciparum resistance to ferroquine (SSR97193) in field isolates and in W2 strain under pressure
W Daher et al.
MALARIA JOURNAL (2006)
The past, present and future of antifolates in the treatment of Plasmodium falciparum infection
Alexis Nzila
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Artemisone - A highly active antimalarial drug of the artemisinin class
RK Haynes et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2006)
A medicinal chemistry perspective on 4-aminoquinoline antimalarial drugs
Paul M. O'Neill et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2006)
Spiro and dispiro-1,2,4-trioxolanes as antimalarial peroxides: Charting a workable structure-activity relationship using simple prototypes
YX Dong et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem)
C Sisowath et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Piperaquine - A resurgent antimalarial drug
TME Davis et al.
DRUGS (2005)
Sulfonyl-phenyl-ureido benzamidines: a novel structural class of potent antimalarial agents
J Leban et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Identification of an antimalarial synthetic trioxolane drug development candidate
JL Vennerstrom et al.
NATURE (2004)
Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number
RN Price et al.
LANCET (2004)
Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques
S Ramanathan-Girish et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2004)
Artemisinins target the SERCA of Plasmodium falciparum
U Eckstein-Ludwig et al.
NATURE (2003)
Insights into antifolate resistance from malarial DHFR-TS structures
J Yuvaniyama et al.
NATURE STRUCTURAL BIOLOGY (2003)
New class of small nonpeptidyl compounds blocks Plasmodium falciparum development in vitro by inhibiting plasmepsins
SP Jiang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
In vitro and in vivo antimalarial activity of ferrochloroquine, a ferrocenyl analogue of chloroquine against chloroquine-resistant malaria parasites
L Delhaes et al.
PARASITOLOGY RESEARCH (2001)
分享论文
